Gilead faces an antitrust complaint in Brazil over hepatitis C pricing - STAT

Gilead faces an antitrust complaint in Brazil over hepatitis C pricing - STAT

STAT Plus: Gilead faces an antitrust complaint in Brazil over hepatitis C pricing

By ED SILVERMAN

ERIC RISBERG/AP

Advocacy groups argue Gilead carried out "unlawful conduct" that "clearly affects the public interest,” because prices led the government to ration a drug.

READ MORE